tbuckley/cabot-search huggingface dataset:
Pork tapeworm of Cysticercus involving peripheral nerve
Authors: J. S. Nosanchuk
Journal: JAMA (1980)

CYSTICERCOSIS is a disease of known cause and well-defined manifestations. Thus, it is somewhat unexpected to make a new observation in an "old" disease. Here we describe what may be the first example of cysticercus involving the peripheral nervous system. <h3>Report of a Case</h3> A 26-year-old, otherwise healthy woman manifested an enlarging, painful nodule located in the upper, inner area of the left arm immediately over the median nerve. She had experienced paresthesias along the median nerve distribution for several weeks before consulting her physician. The patient was Vietnamese but had lived in the United States for the previous five years. On physical examination, the lesion was found to be a poorly defined 2-cm mobile, nontender nodule located close to the bicipital groove. The lesion was characteristic of a schwannoma. Her complete blood cell count (CBC), chemical profile, and chest roentgenogram were all within normal limits. At surgery, a highly
BALANTIDIUM COLI.
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Diet in Morphine Addiction
Authors: E. Stungo
Journal: BMJ (1945)

<h3>Introduction</h3> Current evidence suggests that heart rate (HR) may serve both as a modifiable risk factor, and as a disease modifying variable in patients with impaired left ventricular (LV) systolic function. The systolic heart failure (HF) treatment with I<sub>f</sub> inhibitor ivabradine trial (SHIFT) for example recently demonstrated significantly improved outcomes in otherwise optimally treated HF patients following additional HR reduction with ivabradine. We therefore estimated the number of patients who after optimisation of conventional HF medications may be suitable for additional HR reduction. <h3>Methods</h3> We performed a retrospective analysis from two HF clinics where patients are referred for nurse lead, protocol-guided optimisation of conventional HF therapies. Data on patient demographics and classification of HF including; severity (ejection fraction&gt;35% vs ejection fraction≤35%), functional limitation (New York Heart Association; NYHA class), and cause (ischaemic vs non-ischaemic) were recorded. In addition, we collected data on patient9s resting pulse (absolute value and rhythm: sinus vs atrial fibrillation), and blood pressure at the first and last clinic visits. Between the two clinic visits, patients underwent protocol-guided forced up-titration of standard neurohormonal HF therapies. We also collected data on the maximal tolerated doses of beta blocker (βB), ACE inhibitor (ACE-I) or angiotensin receptor blocker (ARB), and the reasons for the inability to achieve target doses of βB. <h3>Results</h3> Of 172 consecutive patients referred for optimisation of HF therapies (age 71±13 yrs, 67% male), 71 (41%) were in atrial fibrillation. Of the patients in sinus rhythm, 78% had severe LV systolic dysfunction (Abstract 93 figure 1). Overall, 145 of 172 patients (83%) tolerated βB therapy; of these, 39% achieved the target maximal dose, 57% at least half target dose, and 4% less than half of the target dose of βB. Reasons for failure to initiate βB (n=27, 17%) included; severe and limiting hypotension (48%), intractable lethargy (26%), and hospitalisation with worsening airways disease (26%). ACE-I/ARB, aldosterone antagonists, and digoxin were tolerated in 92%, 30%, and 18% of patients respectively (Abstract 93 table 1). Resting heart rate and blood pressure before and after optimisation of medical therapy are shown in Abstract 93 table 2. <h3>Conclusions</h3> Of 172 unselected patients attending HF clinics for optimisation of medical therapy, ∼50% are in sinus rhythm with an ejection fraction ≤35%. Despite forced optimisation of medical therapy, half of these patients have a resting heart rate ≥70 beats/minute. Overall, ∼1 in every 3 patients attending a heart failure clinic may be suitable for additional heart rate control.
Vestibulospinal Reflexes: VI. Relationship Between Vestibulospinal and Vestibulo-Ocular Reflexes in Normal Subjects Following Thermal Stimulation
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The trips of slips. Time delays in laboratory and X-ray data for outpatients in a teaching hospital
Authors: H. G. Dove
Journal: JAMA (1980)

The laboratory and x-ray studies performed on 148 outpatients were monitored to see how long it took for the results to be obtained, reviewed, and inserted into the medical record. An average of 27.0 days was required for all of these tasks. This mundane, unwieldy problem clearly deserves more attention, especially in outpatient clinics at teaching hospitals. (<i>JAMA</i>243:537-539, 1980)
Association of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk—Reply
Journal: JAMA (2004)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Therapeutic Triptych
Authors: Jesse Reed Gutnick
Journal: JAMA (2009)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Safe Motherhood
Authors: Rebecca Voelker
Journal: JAMA (1998)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Anticoagulant Usefulness, Hazards—A Review of 'Accumulated Evidence'
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Immunopathogenesis And Immunotherapy Of Type-1 Diabetes
Authors: K Wilson
Journal: Annual Review of Medicine (1990)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), emerged in China in December 2019 and quickly spread around the globe, killing more than 4 million people and causing a severe economic crisis. ...Read More
Hemorrhagic Nephritis
Authors: JAMES P.  O'HARE, ESLEY J.  KIRK
Journal: Annals of Internal Medicine (1930)

Article1 March 1930Hemorrhagic NephritisJAMES P. O'HARE, M.D., ESLEY J. KIRK, M.D.JAMES P. O'HARE, M.D.Search for more papers by this author, ESLEY J. KIRK, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-3-9-920 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIt seems desirable to present to you briefly the subject of hemorrhagic nephritis for several reasons:-(1) Although the disease is fast being recognized as a definite entity, there is still but little in the literature to indicate such recognition.(2) Undoubtedly many cases are prematurely discharged as cured. Knowledge of the disease and more careful and accurate urinalyses should indicate that the renal lesions persist and that treatment must be continued to avoid a chronic nephritis and death.(3) Fairly often these cases fall into the hands of the G. U. surgeon because of the hematuria. All too frequently... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston, Mass.*From the Medical Clinic of the Peter Bent Brigham Hospital. Read at a meeting of the American College of Physicians, April 8-12, 1929.Work assisted in part by the Fund for Research in Renal and Vascular Disease.*Atlantic Medical Journal, 1923. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 March 1930Volume 3, Issue 9Page: 920-923KeywordsChronic kidney diseaseFallsHospitalsLesionsNephritisRenal diseasesResearch fundingSurgeonsVascular diseases ePublished: 1 December 2008 Issue Published: 1 March 1930 PDF downloadLoading ...
Incorrect Funding/Support Section
Authors: Altaf Saadi
Journal: JAMA (2018)

Christopher D. Gardner, PhD; John F. Trepanowski, PhD; Liana C. Del Gobbo, PhD; Michelle E. Hauser, MD; Joseph Rigdon, PhD; John P. A. Ioannidis, MD, DSc; Manisha Desai, PhD; Abby C. King, PhD
Depressed Physicians
Authors: Harry E. Guda
Journal: JAMA (1979)

<h3>To the Editor.—</h3> It is time for action. Every week, it is not unusual to read of a physician suicide in the obituary section ofThe Journal. It saddens and scares me. I am a depressed physician who has experienced fairly severe chronic, recurrent depression for almost 15 years. What I want to propose to all depressed physicians in all the states of this nation is very simple. I believe that depressed physicians could meet and organize in some regional or central fashion. It would mean banding together in a supportive, self-help, confidential group for the purpose of finding ways and means to cope with depression, to live more effectively, and to find greater satisfactions in living. Perhaps we could overcome the obvious defenses that keep us apart and experience the common denominators that we share—being physicians and being depressed. Definitely, this grouping should be organized as free, nonprofit, independent-type
G-rrrrrrrrrrrr
Authors: Ffrangcon Roberts
Journal: JAMA (1963)

<h3>To the Editor:</h3> —In my opinion "hypsarrhythmia" must be correct. In words beginning with<i>rh</i>, eg,<i>rheumatic, h</i>is the English representation of the Greek rough breathing, c placed over the<i>r</i>, thus:<i>p</i>. In Greek, when rh is preceded by a prefix—<i>dia</i>-,<i>haemo</i>-, etc.—<i>r</i>is duplicated (<i>rr</i>) and the rough breathing is omitted from the written word though retained in the spoken word. In English and other Western languages, -<i>rrh</i>- has been conventionally adopted as a phonetic representation of the Greek, eg,<i>diarrhoea</i>. In short, the rule is<i>rh</i>at the beginning of a word and<i>rrh</i>after all prefixes. Although this is no more than a convention, the important thing is that writers should be consistent. [Notwithstanding the fact that it may cause a high arrhythmia, we have decided to "go in for" hypsarrhythmia. Finally, for what happened to the missing "r," see "Sicca (Sjörgren's) [sic]
A new model of care for patients with central nervous system cancers.
Authors: Kathryn Sara Nevel, Franchesca Konig, Anna Skakodub, Mary Elizabeth Davis, Maryann Sibilla, Mabel Harrison, Gayle Rawlins-Peters, Dominique Jean-Charles, Anastasia Zankowsky, Jody Gilman, Brian Kelly, Stephanie Zavolas, Anne S. Reiner, Katherine Panageas, Eli L. Diamond, Alan Carver, Lisa Marie DeAngelis, Kara Barnett, Lisa Marie Ruppert, Elena Pentsova
Journal: Journal of Clinical Oncology (2019)

e18029 Background: Patients (pts) with primary or metastatic central nervous system (CNS) cancers often have multiple physical, psychosocial, and spiritual needs. Neurological impairments can transform relationship dynamics as loved ones become caregivers. These issues are difficult to address within a single outpatient oncology clinic. Methods: The Neurological Multidisciplinary Care Clinic (MdCC) at Memorial Sloan Kettering Cancer Center was a pilot study from 08/2017 to 01/2019 to foster a new model of care for complex pts with CNS cancers to identify and address their needs. The MdCC team, comprised of a neurologist, nurse, physiatrist, physical therapist, social worker(SW), case manager(CM), dietitian(RD), and chaplain. During a 3-hour visit, MdCC providers saw each pt/caregiver. Since 11/2017 participants completed validated surveys on unmet needs, financial strain, and home equipment prior to their visit and satisfaction surveys afterward. Descriptive statistics were used to analyze results. Results: Seventy-six pts were seen: 37 were female, median age 60. Of these 76 pts, 63 had primary CNS cancers; glioblastoma (51%) and high-grade glioma (HGG) (29%). Fifty-five were receiving cancer-directed therapy at the time of MdCC. Over 70% had never seen a SW, CM, RD, or physiatrist prior to MdCC. Pts’ most commonly reported need was “not being able to do the things I used to do”; for caregivers it was “I need my partner to have an ongoing CM.” Seventy-four pts (97%) received symptom management recommendations. Prognosis/coping with cancer was discussed with 70 (92%) which increased signed health care proxy forms by 11% and DNR orders by 3%. New/updated physical therapy was ordered for 48 pts (61%), orthotics for 8 (10%), and new equipment for 12 (15%). Five pts were referred to a food assistance program. Forty-five pts completed a satisfaction survey; of these, 96% were highly satisfied, and would recommend MdCC to others. Conclusions: Pts’/caregivers’ unmet needs were effectively identified and addressed in this new model, and an emphasis on supportive and coordinated care contributed to high pt/caregiver satisfaction. We therefore propose to offer this clinic for all pts with HGG to improve pts’ well-being, quality of care, and increase pt/caregiver satisfaction.
Abstract 9955: Outcomes of Catheter Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy Patients - A Pooled Analysis
Authors: Vivek Yarlagadda, Arun Kanmanthareddy, Parinita A Dherange, Pradyumna Agasthi, Arun Raghav Mahankhali Sridhar, Sudharani Bommana, Donita Atkins, Andrea Natale, Luigi Di Biase, Dhanunjaya Lakkireddy, Madhu Reddy
Journal: Circulation (2015)

Objectives: Atrial fibrillation (AF) is the most common sustained arrhythmia in hypertrophic cardiomyopathy (HCM.) Aggressive rhythm control is recommended for this group of patients and radiofrequency catheter ablation is emerging as a frontline strategy. This pooled analysis aims to study the efficacy and outcomes of AF ablation in HCM patients Methods: PubMed, EMBASE and Google Scholar databases were searched to identify all studies describing the outcomes of catheter ablation of AF in HCM. Data from identified studies was extracted and pooled analysis was carried out using CMA 2 software. Pooled adjusted procedure duration and incident rates of recurrence and adverse events were calculated using random effects model. Results: A total of 11 studies with 384 patients were included in this study. For the index procedure, mean procedural time, radio frequency ablation and fluoroscopy times were 207.3 minutes, 39.7 minutes and 62.4 minutes respectively. The adjusted incidence of major ablation-related complications (death, stroke, transient ischemic attack, peripheral embolism, cardiac tamponade or perforation, valvular damage, arteriovenous fistula requiring surgical intervention, and a large vascular access site hematoma resulting in a drop of hemoglobin level by 2 g/dL) was 4 per 100 procedures (95% CI 2.1 - 7.5%). The recurrence of AF after index ablation during the mean follow up period of 14.5 months occurred in 58% (95% CI 50 -66%) of the patients (Figure1). Conclusion: The results of our analysis suggest that there is a high rate of recurrence of AF in HCM patients who undergo single AF ablation. The risk of complications with AF ablation appears to be low in this group of patients. Further studies are needed to assess the impact of multiple ablations on long term outcomes in these patients.
Inhaled insulin1Abbreviations: DM, diabetes mellitus; AIDs, acquired immune deficiency syndrome; SC, subcutaneous; DCCT, Diabetes Control and Complications Trial; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus; i.v., intravenous; DDPC, di-decanoyl-alpha-phosphatidylcholine; AUC, area under the curve; INH, inhaled; Cmax, maximum serum concentration; Cmin, minimum serum concentration; Tmax, time of maximum serum concentration; NS, not significant; HbA1c…
Authors: John S. Patton, Julie Bukar, Sudha Nagarajan
Journal: Advanced Drug Delivery Reviews (1999)
Medical management of chronic cancer pain
Authors: D. S. Shimm
Journal: JAMA (1979)

Management of the chronic pain of cancer is a common and difficult problem. In addition to a medical examination of the patient, it is necessary to perform a psychological assessment of his premorbid personality, current mental status, and coping mechanisms to devise an individualized approach to his pain. The mainstay of cancer pain control are the narcotics, which differ primarily in potency and duration of action. Nonnarcotic analgesics are equianalgesic with the less potent narcotics. Antipsychotic drugs are useful as tranquilizers, antiemetics, and analgesic potentiators. Antidepressants and hypnotics permit the patient a more normal life-style. Stimulants such as cocaine and amphetamines both potentiate narcotic analgesia and reduce narcotic-induced somnolence and respiratory depression. Tetrahydrocannabinol offers no advantage over traditional analgesics. With care and patience, the physician can render practically any cancer patient pain-free. (<i>JAMA</i>241:2408-2412, 1979)